ES2012508A6 - Metodo para la utilizacion de lineas celulares que carecen de antigenos de hostocompatibilidad de clas humana ii - Google Patents

Metodo para la utilizacion de lineas celulares que carecen de antigenos de hostocompatibilidad de clas humana ii

Info

Publication number
ES2012508A6
ES2012508A6 ES8602252A ES8602252A ES2012508A6 ES 2012508 A6 ES2012508 A6 ES 2012508A6 ES 8602252 A ES8602252 A ES 8602252A ES 8602252 A ES8602252 A ES 8602252A ES 2012508 A6 ES2012508 A6 ES 2012508A6
Authority
ES
Spain
Prior art keywords
human class
histocompatibility antigens
cell lines
methods
utilizing cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES8602252A
Other languages
English (en)
Inventor
Robert Nowinski
Luc Montagnier
David Klatzmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur
Genetic Systems Corp
Original Assignee
Institut Pasteur
Genetic Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur, Genetic Systems Corp filed Critical Institut Pasteur
Publication of ES2012508A6 publication Critical patent/ES2012508A6/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C07K16/114—
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C12N5/0694—Cells of blood, e.g. leukemia cells, myeloma cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56977—HLA or MHC typing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
    • C12N2740/14051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15051—Methods of production or purification of viral material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/974—Aids related test

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measurement Of Length, Angles, Or The Like Using Electric Or Magnetic Means (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

METODO PARA LA UTILIZACION DE LINEAS CELULARES QUE CARECEN DE ANTIGENOS DE HISTOCOMPATIBILIDAD DE CLASE HUMANA II. EL METODO COMPRENDE MANTENER UN CULTIVO VIABLE DE CELULAS QUE CARECEN DE ANTIGENOS DE HISTOCOMPATIBILIDAD DE CLASE HUMANA II EN UN MEDIO DE CULTIVO NUTRIENTE, INOCULAR EL CULTIVO CON UN VIRUS AL CUAL SON SUSCEPTIBLES LAS CELULAS Y PROPAGAR SUBSIGUIENTEMENTE EL VIRTUS EN EL CULTIVO, QUE COMPRENDE UN HUESPED CELULAR QUE CONSISTE EN UNA LINEA CELULAR CONTINUA. LA INVENCION ES APLICABLE A LA DETERMINACION DE LA PRESENCIA Y/O PROPORCION DE ANTICUERPOS DE UN MICROORGANISMO EN UN FLUIDO BIOLOGICO.
ES8602252A 1985-09-13 1986-09-12 Metodo para la utilizacion de lineas celulares que carecen de antigenos de hostocompatibilidad de clas humana ii Expired - Lifetime ES2012508A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77584285A 1985-09-13 1985-09-13

Publications (1)

Publication Number Publication Date
ES2012508A6 true ES2012508A6 (es) 1990-04-01

Family

ID=25105682

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8602252A Expired - Lifetime ES2012508A6 (es) 1985-09-13 1986-09-12 Metodo para la utilizacion de lineas celulares que carecen de antigenos de hostocompatibilidad de clas humana ii

Country Status (11)

Country Link
US (1) US5514542A (es)
EP (3) EP0646793A3 (es)
JP (1) JPS62115278A (es)
AT (1) ATE132896T1 (es)
AU (2) AU6262786A (es)
DE (1) DE3650468T2 (es)
DK (1) DK439086A (es)
ES (1) ES2012508A6 (es)
GR (1) GR862335B (es)
PT (1) PT83368B (es)
ZA (1) ZA866956B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8605535L (sv) * 1986-12-22 1988-06-23 Birgitta Asjo Cellsystem, dess framstellning och anvendning
US7485293B1 (en) 1999-02-18 2009-02-03 Faustman Denise L Method for inhibiting transplant rejection
US20040133439A1 (en) * 2002-08-21 2004-07-08 Dirk Noetzold Method and system for valuation of complex systems, in particular for corporate rating and valuation
US8405379B1 (en) 2008-09-18 2013-03-26 Luc Montagnier System and method for the analysis of DNA sequences in biological fluids

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3135599A1 (de) * 1981-09-09 1983-08-25 Flehmig Bertram An menschliche fibroblastenzellen adaptierte hepatitis-a-viren
JPS59141519A (ja) * 1983-01-31 1984-08-14 Otsuka Pharmaceut Co Ltd 制ガン作用を有する蛋白質
JPS6045535A (ja) * 1983-08-16 1985-03-12 Japan Found Cancer Ｂ型肝炎ウイルスワクチンの製造法
GB8324800D0 (en) * 1983-09-15 1983-10-19 Pasteur Institut Antigens
US4520113A (en) * 1984-04-23 1985-05-28 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Serological detection of antibodies to HTLV-III in sera of patients with AIDS and pre-AIDS conditions
US4652599A (en) * 1984-04-23 1987-03-24 The United States Of America As Represented By The Department Of Health And Human Services Method of continuous production of retroviruses (HTLV-III) from patients with AIDS and pre-AIDS using permissive cells
US4716102A (en) * 1984-08-15 1987-12-29 Regents Of The University Of California Purified AIDS-associated virus ARV-2
US4725669A (en) * 1984-11-09 1988-02-16 President And Fellows Of Harvard College Assay for detecting infection by human T-cell lymphotropic virus-III
US4877725A (en) * 1985-04-01 1989-10-31 New York Blood Center, Inc. Immunoassays for antibodies which bind to the acquired immunodeficiency virus

Also Published As

Publication number Publication date
ZA866956B (en) 1987-11-25
DE3650468T2 (de) 1996-09-05
PT83368A (en) 1986-10-01
EP0664337A1 (en) 1995-07-26
AU651951B2 (en) 1994-08-11
GR862335B (en) 1987-01-13
EP0220970A3 (en) 1989-02-08
EP0646793A2 (en) 1995-04-05
DE3650468D1 (de) 1996-02-22
AU6262786A (en) 1987-03-19
PT83368B (pt) 1989-05-12
DK439086A (da) 1987-03-14
EP0646793A3 (en) 1995-07-12
ATE132896T1 (de) 1996-01-15
EP0220970B1 (en) 1996-01-10
US5514542A (en) 1996-05-07
EP0220970A2 (en) 1987-05-06
DK439086D0 (da) 1986-09-12
JPS62115278A (ja) 1987-05-26
AU6659390A (en) 1991-04-18

Similar Documents

Publication Publication Date Title
YU45871B (sh) Polipeptid sa humanim imunointerferonskim (ifn-gama) svojstvima
ES2113346T3 (es) Metodo para potenciar el transporte de moleculas exogenas a traves de la membrana.
ES2129020T3 (es) Inmunoterapia que utiliza el estimulo de la cd28.
ES397784A1 (es) Procedimiento para la produccion microbiologica de composi-ciones proteinicas.
ES2012508A6 (es) Metodo para la utilizacion de lineas celulares que carecen de antigenos de hostocompatibilidad de clas humana ii
ES2118827T3 (es) Procedimiento y medio de cultivo celular para el cultivo de celulas animales adherentes.
KR870700096A (ko) 유용한 메탈로프로테이나제 억제제 씨퀀스 재결합 보균자계와 그의 제조를 위한 dna 재결합방법
Lichstein et al. On the permeability of Lactobacillus arabinosus to biotin
Mandelbaum STUDIES OF THE ROLE OF CYCLIC AMP AND PROTEIN PHOSPHORYLATION IN THE MEDIATION OF FOOD AROUSAL IN APLYSIA.
Richards CONSTRAINT THEORY: AN APPROACH TO POLICY-LEVEL MODELLING.
Rosen THE USE OF CULTURED VASCULAR ENDOTHELIAL CELLS AS AN IN VITRO MODEL FOR CELLULAR SENESCENCE.
Ziegler The production and purification of duck interferon and its effect on the multiplication of B77 avian RNA tumor virus in duck embryo fibroblasts.
Armbruster Sporangiogenesis and spore discharge in members of the Saprolegniaceae.
Hansen An in vitro and in vivo study of the pathogenesis of mouse hepatitis virus-4 infection.
Morrison CURRENT PRACTICES IN THE ASSESSMENT OF INSTITUTIONALIZED SEVERELY RETARDED DEAF-BLIND ADOLESCENTS.
AULL CROPLAND, BUFFER, AND STREAM: A CASE STUDY IN AGRICULTURAL NONPOINT SOURCE WATER POLLUTION.
Butler Reproductive performance and energetic efficiency as influenced by body composition in primiparous beef heifers.
Memon Effects of prostaglandins on ram spermatozoa.
Persky Stereo-scanning electron microscopy of the canine subarachnoid space after injection of defibrinated chicken red blood cells.
Clemens ROLE OF EXTRACELLULAR ADENOSINE TRIPHOSPHATE DURING HYPOXIA AND CALCIUM DEPRIVATION IN THE ISOLATED WORKING RAT HEART.
Martin RELATIONSHIP BETWEEN SELF-ESTEEM AND A SELF-ENHANCING MANAGEMENT SYSTEM.
Timpano A STUDY OF THE FRESH WATER PHAEOPHYTE, SPHACELARIA FLUVIATILIS.
George HUMMINGBIRD FORAGING BEHAVIOR AND POLLINATION ENERGETICS OF MALVAVISCUS ARBOREUS.
Haug OPTIMIZATION OF SLURRY TRENCH CUTOFF DESIGN.
AT339848B (de) Fermenter zur zuchtung von mikroorganismen, insbesondere von backhefe

Legal Events

Date Code Title Description
SA6 Expiration date (snapshot 920101)

Free format text: 2006-09-12